Updated Jul 16, 2026
Kidron Miriam is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Miriam Kidron is the Chief Scientific Officer at Oramed Pharmaceuticals Inc., a company focused on the oral delivery of therapeutic proteins. She has been involved in the pharmaceutical industry, contributing to the development of innovative drug delivery systems.
| Role | Chief Scientific Officer, Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | ORMP | ORAMED PHARMACEUTICALS INC. | F — Tax withholding / forfeiture | 435.1K | $3.31 | $1.44M |
| 2026-03-27 | LFWD | Lifeward Ltd. | A — Grant or award | 7.7K | $0.00 | |
| 2026-03-18 | ORMP | ORAMED PHARMACEUTICALS INC. | A — Grant or award | 119.6K | $0.00 | |
| 2026-01-29 | ORMP | ORAMED PHARMACEUTICALS INC. | M — Option exercise | 19.0K | $0.00 | |
| 2026-01-21 | ORMP | ORAMED PHARMACEUTICALS INC. | G — Bona-fide gift | 86.2K | $0.00 | |
| 2026-01-05 | ORMP | ORAMED PHARMACEUTICALS INC. | A — Grant or award | 115.0K | $0.00 | |
| 2026-01-05 | ORMP | ORAMED PHARMACEUTICALS INC. | A — Grant or award | 121.3K | $0.00 | |
| 2024-11-08 | ORMP | ORAMED PHARMACEUTICALS INC. | A — Grant or award | 30.0K | — |
Miriam Kidron is the Chief Scientific Officer at Oramed Pharmaceuticals Inc., a company focused on the oral delivery of therapeutic proteins. She has been involved in the pharmaceutical industry, contributing to the development of innovative drug delivery systems.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kidron Miriam profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.